Research ArticleArticle
Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence
Boying Guo, Alicia Rodriguez-Gabin, Andrea Prota, Tobias Mühlethaler, Nan Zhang, Kenny Ye, Michel O Steinmetz, Susan Band Horwitz, Amos B Smith III and Hayley McDaid
Molecular Pharmacology June 26, 2020, mol.119.117457; DOI: https://doi.org/10.1124/mol.119.117457
Boying Guo
1 University of Pennsylvania;
Alicia Rodriguez-Gabin
2 Albert Einstein College of Medicine;
Andrea Prota
3 Paul Scherrer Institut;
Tobias Mühlethaler
3 Paul Scherrer Institut;
Nan Zhang
1 University of Pennsylvania;
Kenny Ye
2 Albert Einstein College of Medicine;
Michel O Steinmetz
4 University of Basel;
Susan Band Horwitz
2 Albert Einstein College of Medicine;
Amos B Smith III
1 University of Pennsylvania;
Hayley McDaid
5 Albert Einstein College of medicine

Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence
Boying Guo, Alicia Rodriguez-Gabin, Andrea Prota, Tobias Mühlethaler, Nan Zhang, Kenny Ye, Michel O Steinmetz, Susan Band Horwitz, Amos B Smith and Hayley McDaid
Molecular Pharmacology June 26, 2020, mol.119.117457; DOI: https://doi.org/10.1124/mol.119.117457
Research ArticleArticle
Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence
Boying Guo, Alicia Rodriguez-Gabin, Andrea Prota, Tobias Mühlethaler, Nan Zhang, Kenny Ye, Michel O Steinmetz, Susan Band Horwitz, Amos B Smith and Hayley McDaid
Molecular Pharmacology June 26, 2020, mol.119.117457; DOI: https://doi.org/10.1124/mol.119.117457